Back to School: How biopharma can reboot drug development. Access exclusive analysis here

131-I-TM-601: Transmolecular started a U.S. Phase I/II trial in 18 patients with recurrent high-grade glioma. Originally the trial was planned to have started i

Transmolecular Inc., Birmingham, Ala.
Product: 131-I-TM-601

Read the full 61 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE